JP Stock MarketDetailed Quotes

2160 GNI Group

Watchlist
  • 2237
  • 00.00%
20min DelayMarket to Open Apr 24 15:30 JST
112.36BMarket Cap105.77P/E (Static)

About GNI Group Company

GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.

Company Profile

Symbol2160
Company NameGNI Group
Founded2001-11-20
MarketTSE Growth
Employees867
Fiscal Year Ends12-31
AddressShinjuku Park Tower 3-7-1 Nishi-Shinjuku
Zip Code103-0023
Phone03-6214-3600

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Ying Luo, PhD
  • Director, Representative Executive Officer, President and Chief Executive Officer
  • --
  • Toshiya Kitagawa
  • Director, Executive Officer and Chief Financial Officer
  • --
  • Sekitani Kazuki
  • Director, Executive Officer and Chief Operating Officer
  • --
  • Thomas Eastling
  • Director
  • --
  • Ryosuke Matsui
  • Director
  • --
  • Kikuchi Kanako
  • Independent Director
  • --
  • Zhang Ping
  • Independent Director
  • --
  • Hideaki Sashiwa
  • Independent Director
  • --

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More